Machine learning reveals pre-treatment deficit accumulation as a predictor of persistent cancer-related fatigue: The Thinking and Living with Cancer longitudinal cohort study
Year: 2026
Type: article
Study design: Observational Study
Abstract: INTRODUCTION: Cancer-related fatigue is a long-term, distressing symptom among older survivors. However, predictors of fatigue are not well defined. We used machine learning to identify pre-treatment factors that predict persistent fatigue among older breast cancer survivors. MATERIALS AND METHODS: Participants were women ages ≥60 with non-metastatic breast cancer enrolled pre-systemic treatment (n = 543) and age, race, and site-matched controls without a cancer history (n = 496). Fatigue was assessed using the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) fatigue subscale at baseline, one year, and two years; persistent fatigue was defined as ≤34 points at year one and/or two. Baseline variables included demographics, medical history, lifestyle habits, symptoms, a 46-item deficit accumulation index (DAI; an indicator of frailty) score, and cancer and treatment details (survivors only), yielding 90 variables for survivors and 82 for controls. Logistic regression with Lasso variable selection, Stochastic Gradient Boosting, Random Forest, and Boruta machine learning models were applied to assess factors that predicted persistent fatigue. RESULTS: Participants were 68.4 ± 6.1 years; 14.4% of survivors and 8.1% of controls reported persistent fatigue (p = 0.002). Model performance was strong across algorithms (corrected AUROC range: 0.74-0.83). For all participants, predictors of persistent fatigue included higher baseline fatigue, as measured using the FACIT-F total score or FACIT-F fatigue subscale score. Notably, higher pre-treatment DAI score was a strong predictor among survivors across all models (p < 0.001) but was selected by only one model for controls. DISCUSSION: Greater pre-treatment DAI score was predictive of persistent fatigue in older breast cancer survivors. Thus, a higher DAI score may be a useful clinical indicator of fatigue risk, helping target intervention efforts for these patients. CLINICALTRIALS: gov identifier:NCT03451383.
Source: Journal of Geriatric Oncology
Institutions: University of Maryland, Baltimore, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Georgetown University, Memorial Sloan Kettering Cancer Center, Duke University, Duke Medical Center, Moffitt Cancer Center, University of California, Los Angeles, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, City Of Hope National Medical Center, Baltimore VA Medical Center, University of North Carolina at Chapel Hill, Georgetown Lombardi Comprehensive Cancer Center
Language: English
Topic: Cancer survivorship and care
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: cancer-related fatigue, persistent fatigue
Open Access status: hybrid
Estimated APC paid: $3,610
Awards: Heterogeneity in biological, physical, and cognitive aging in older breast cancer survivors and controls, G1499896176, Cognitive Aging, Alzheimers disease, and Cancer-related Cognitive Decline, Bio-behavioral Research At The Intersection of Cancer and Aging, Older Breast Cancer Patients: Risk For Cognitive Decline, Time-restricted eating to address cancer-related fatigue among survivors of hematological malignancies, I-REACH (Infrastructure for REsearch on Cancer and Aging), Investigations CONNECTing Cancer and Aging (I-CONNECT), University of Maryland Claude D. Pepper Older Americans Independence Center (OAIC), Patterns of biological, cognitive, and physical aging in cancer survivors and controls and the role of sleep health: Relevance for Alzheimer's Disease and Related Dementias
OpenAlex ID: W7226011304
